{"product_id":"dental-bone-graft-substitute-market-size-share-covid19-impact-analysis-united-states-2023-2029-medsuite-includes-dental-bone-graft-substitutes-dental-barrier-membranes-and-3-more","title":"Dental Bone Graft Substitute Market Size, Share \u0026 COVID19 Impact Analysis | United States | 2023-2029 | MedSuite | Includes: Dental Bone Graft Substitutes, Dental Barrier Membranes, and 3 more","description":"\u003cp\u003eDental Bone Graft Substitute Market Size, Share \u0026amp; COVID19 Impact Analysis | United States | 2023-2029 | MedSuite | Includes: Dental Bone Graft Substitutes, Dental Barrier Membranes, and 3 more\u003c\/p\u003e\n\n\u003cp\u003eThe U.S. dental bone graft substitute and other biomaterials market had a value of $589 million in 2022 and is projected to grow at a CAGR of 5.3% during the forecast period, reaching a value of over $847 million. The comprehensive report suite on the U.S. dental bone graft substitutes market comprises several segments, including dental bone graft substitutes, dental growth factors, dental barrier membranes, local antimicrobial periodontal treatments, and dental soft tissue regeneration, all of which together form the dental biomaterials market.\u003c\/p\u003e\n\n\u003cp\u003eDATA TYPES INCLUDED IN THIS REPORT\u003c\/p\u003e\n\n\u003cp\u003eUnit Sales, Average Selling Prices, Market Value \u0026amp; Growth Trends\u003cbr\u003e\nMarket Forecasts Until 2029 \u0026amp; Historical Data to 2019\u003cbr\u003e\nCompetitive Analysis with Market Shares for Each Market Segment\u003cbr\u003e\nMarket Drivers \u0026amp; Limiters\u003cbr\u003e\nRecent Mergers \u0026amp; Acquisitions\u003cbr\u003e\nCOVID19 Impact on the DBGS Market in the US\u003cbr\u003e\nDisease Overviews \u0026amp; Demographic Information\u003cbr\u003e\nCompany Profiles, Product Portfolios \u0026amp; SWOT for Top Competitors\u003c\/p\u003e\n\n\u003cp\u003eU.S. DENTAL BONE GRAFT SUBSTITUTE MARKET TRENDS\u003c\/p\u003e\n\n\u003cp\u003eThe dental bone graft substitute market is closely linked to the growth of the dental implant and final abutment markets, with over half of dental implant procedures requiring bone grafting beforehand. The U.S. dental implant market is expected to see significant growth over the forecast period, which will in turn drive demand for dental bone graft substitutes. As the dental implant market continues to expand, so too will the demand for dental bone graft substitutes.\u003c\/p\u003e\n\n\u003cp\u003eU.S. DENTAL BONE GRAFT SUBSTITUTE MARKET SHARE INSIGHTS\u003c\/p\u003e\n\n\u003cp\u003eThe dental bone graft substitute market in the U.S. is largely controlled by four main competitors: Geistlich, ZimVie, OraPharma and BioHorizons. The remainder of the market is made up of smaller competitors and various tissue banks that distribute primarily through various companies in the market.\u003c\/p\u003e\n\n\u003cp\u003eGeistlich emerged as the leading player in the dental bone graft substitute and other biomaterials market, with significant market shares in the dental bone graft substitute, dental barrier membrane, and dental soft tissue regeneration segments. The company's focus on regenerating bone, cartilage, and tissue has given it a competitive edge in the market. In October 2022, Geistlich further solidified its position by acquiring Lynch Biologics and obtaining the rights to its GEM 21S® dental growth factor product. With only four dental growth factor products available in the U.S. market, this acquisition sets Geistlich apart and strengthens its presence in the dental bone graft substitute market.\u003c\/p\u003e\n\n\u003cp\u003eMARKET SEGMENTATION SUMMARY\u003c\/p\u003e\n\n\u003cp\u003eDental Bone Graft Substitute Market | United States | 2023-2029 – Includes:\u003cbr\u003e\nAllograft, xenograft and synthetic material sub-segments.\u003cbr\u003e\nDental Barrier Membrane Market | United States | 2023-2029 – Includes:T\u003cbr\u003e\nResorbable and non-resorbable dental barrier membrane segments.\u003cbr\u003e\nDental Growth Factor Market | United States | 2023-2029 – Includes:\u003cbr\u003e\nStraumann’s Emdogain®, Lynch Biologics’ GEM 21S®, Medtronic’s Infuse® and NuVasive’s Osteocel® (distributed by ACE SOUTHERN).\u003cbr\u003e\nLocal Antimicrobial Periodontal Treatment Market | United States | 2023-2029\u003cbr\u003e\nDental Soft Tissue Regeneration Market | United States | 2023-2029 – Includes:\u003cbr\u003e\nDental soft tissue regeneration market and dental soft tissue wound care market segments.\u003c\/p\u003e\n\n\u003cp\u003eRESEARCH SCOPE SUMMARY\u003c\/p\u003e\n\n\u003cp\u003eRegions\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"March, 2023 \/ 251 Pages \/ MCW16228981","offer_id":47646898946354,"sku":null,"price":9594.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/dental-bone-graft-substitute-market-size-share-covid19-impact-analysis-united-states-2023-2029-medsuite-includes-dental-bone-graft-substitutes-dental-barrier-membranes-and-3-more","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}